![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2407 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Brégand, Eric (TEMIS 200809 CEO) | Chief Executive Officer (CEO) | Expert System (Group) | Île-de-France (region) |
| Bregenholt, Søren (Alligator Bioscience 202106– CEO before Macrophage Pharma + Novo Nordisk + Symphogen) | Chief Executive Officer (CEO) | Alligator Bioscience (Group) | Skåne |
| Brennan, Andrew (Novasep 201609 General Manager of US Operations) | General Manager (management) | Novasep (Group) | Pennsylvania (federal state) |
| Brennan, John (EuropaBio –201808 Secretary General LEFT 9/18) | lobbying | EuropaBio aisbl – the European Association of Bioindustries | Brussels (region) |
| Brepson, Jean-Francois (PathoQuest 201610 CEO) | Chief Executive Officer (CEO) | PathoQuest SAS | Île-de-France (region) |
| Breton, Pascal (VitamFero 201106 CEO) | Chief Executive Officer (CEO) | VitamFero S.A. | Île-de-France (region) |
| Brett, Catherine (Innovative Medicines Initiative 201807 External Relations Manager) | President/Director/Head Business Group/Unit/Division | Innovative Health Initiative (IHI JU) | EU (European Union)_o |
| Breum, Casper (Sound Bioventures 202201 Founding Partner before Novo Nordisk + Lundbeck + Lundbeckfonden Ventures) | Partner (venture partner) | Sound Bioventures (Group) | Skåne |
| Brichant, Damien (Novasep 201412 Asia Pacific Manager) | Regional manager | Novasep (Group) | Grand Est (Great East) (region) |
| Brichard, Vincent (Life Sciences Partners 2016– Venture Partner before GSK SVP + Head of Immunotherapeutics) | Partner (venture partner) | EQT (Wallenberg family) (Group) | North Holland (province, NL) |
| Bricout, Pascal (Carbios 202209– Chief Strategy + Financial Officer before Michelin in Asia) | Chief Financial Officer (CFO) | Carbios (Group) | Auvergne-Rhône-Alpes (region) |
| Brisard, Arnaud (SpineVision 201411 CEO) | Chief Executive Officer (CEO) | SpineVision S.A. | Île-de-France (region) |
| Brochard, Jean-Francois (GSK 201609 General Manager GSK France) | n. a. | GSK (Group) | Greater London (region) |
| Brochette, Hervé (Weezion 202205 CEO + Co-Founder) | Chief Executive Officer (CEO) | Weezion SAS | Auvergne-Rhône-Alpes (region) |
| Brodard, Lionel (MedXCell 202106 CFO) | Chief Financial Officer (CFO) | MedXCell (Group) | Région Lémanique (region) |
| Bronstein, Liliane (ElsaLys 201701– VP Finance) | Chief Financial Officer (CFO) | Mediolanum (Group) | Auvergne-Rhône-Alpes (region) |
| Brosgart, Carol L. (Univ California 201801 Prof at UCSF Dept of Medicine before Alios BioPharma + Gilead Sciences) | Professor | University of California (System) | California (federal state) |
| Brouchot, Valentine (NewCap. 201404) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | Île-de-France (region) |
| Brown, Clive G. (Oxford Nanopore 201103 CTO) | Chief Technology/Technical Officer (CTO) | Oxford Nanopore (Group) | South East England (region) |
| Brown, Colin (Roche 201112 Head of Roche Professional Diagnostics) | President/Director/Head Business Group/Unit/Division | Roche (Group) | Indiana (federal state) |
| Brown, Frank (Accelrys 200609– before 1997–2006 JnJ) | n. a. | Dassault Systèmes (3DS) (Group) | California (federal state) |
| Brown, Rob (Dotmatics 201501– VP Global Informatics before Biovia/Dassault Systèmes + Accelrys) | President/Director/Head Business Group/Unit/Division | Insightful Science (Group) | East of England (region) |
| Brown, Stephanie (Santhera 202112– President North America + Executive Board Member before Ipsen US + Novartis US) | Board member, executive | Santhera (Group) | Massachusetts (federal state) |
| Brun, Virginie (PX'Therapeutics 201008– CSO + co-founder of Promise Advanced Proteomics) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Aguettant (Group) | Auvergne-Rhône-Alpes (region) |
| Bryant, David (Eurofins 201802 Group SVP Food Testing North America) | President/Director/Head Business Group/Unit/Division | Eurofins (Group) | Flanders (Flemish region) |
| Brücher, Christoph | n. a. | Sanofi (Group) [since May 2011] | Hessen (Hesse) (federal state) |
| Brügemann, Lutz (Bruker 200905 Director RnD + Marketing) | n. a. | Bruker (Group) | United States (USA)_o |
| Bucaille, Pauline (Euronext 201710 Chief Communications Officer) | public relations / investor relations | Euronext (Group) | Île-de-France (region) |
| Buchanan, Iain (Noxxon 201009– interim CEO before Novexel CEO before Vertex Pharmaceuticals) | Chief Executive Officer (CEO) | TME Pharma (Group) | Berlin (federal state) |
| Buckle, Isabelle (Institut Pasteur 201607 EVP Technology Transfer + Industrial Partnerships) | IP Manager | Institut Pasteur | Île-de-France (region) |
| Buhl Jensen, Peter (Univ Copenhagen 201112 Prof + CEO LiPlaseom Pharma before Topotarget Co-founder + CEO 2001–2010) | Professor | University of Copenhagen | Hovedstaden |
| Buhl, Thomas (Global Bioenergies 201606 Head of Business Development) | Business Development Manager / Strategy Manager | Global Bioenergies (Group) | Île-de-France (region) |
| Bui, Tram (Ruth Group 201807) | Public Relations Manager / Investor Relations Manager | Ruth Group, The (TRG) | New York (federal state) |
| Bulc, Ales (Global Bioenergies 201606 CEO of Global Bioenergies GmbH) | Chief Executive Officer (CEO) | Global Bioenergies (Group) | Sachsen (federal state) |
| Bunting, Stephen (Abingworth 200701 Managing Director) | Managing Director | Carlyle (Group) | Greater London (region) |
| Buono, Stefano (Advanced Accelerator Applications 201402 CEO) | Chief Executive Officer (CEO) | Novartis (Group) | Rhône-Alpes (region) [before 2015] |
| Burbridge, Mike (Servier 201709 Director Translational + Clinical Research in Oncology) | Research & Development Manager | Servier (Group) | Île-de-France (region) |
| Burema, Peter (NextPharma 202101 CEO) | Chief Executive Officer (CEO) | NextPharma (Group) | South East England (region) |
| Burgard, Luc (Sartorius 202111 Managing Director Sartorius Stedim FMT + Head of Operations Bioprocess Solutions Div) | Managing Director | Sartorius (Group) | Provence-Alpes-Côte d’Azur (region) |
| Burgess, Daniel (Dan) (Pulmocide 202105 CEO + Venture Partner at SV Health Investors before Rempex + Mpex) | Chief Executive Officer (CEO) | Pulmocide Ltd. | Greater London (region) |
| Burt, Thomas (Tom) (Sofinnova Partners 202110 Partner) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Buswell, Brad (Safran 201107 CEO of Morpho Detection Inc) | Chief Executive Officer (CEO) | Safran (Group) | California (federal state) |
| Butt, Neil (Orbit Discovery 202106– CEO before Iontas + Abzena + Antitope) | Chief Executive Officer (CEO) | T-Cypher Bio Ltd. | South East England (region) |
| Butterfield, Stewart (Slack Technologies 202012 CEO + Co-Founder) | Chief Executive Officer (CEO) | Salesforce (Group) | United States (USA)_o |
| Bühler, Peter (Valneva 202107– CFO ANNOUNCED before Quotient + Zaluvida + Stallergenes Greer + Lilly + Merck Serono) | Chief Financial Officer (CFO) | Valneva (Group) | Pays de la Loire (region) |
| Böhmer Christoph (ArchiMed 201609 Operating Partner before McKinsey + Biotronik) | Investment Manager | ArchiMed (Group) | Auvergne-Rhône-Alpes (region) |
| Cabirol, Fabien (L’Oréal 201501 Global Head of Biotechnologies Dept) | President/Director/Head Business Group/Unit/Division | L’Oréal (Group) | Île-de-France (region) |
| Cachat, Jocelyne (Dominique Dutscher 201607 Marketing Director) | Sales Manager / Marketing Manager | Dutscher (DD) (Group) | Grand Est (Great East) (region) |
| Cado, Sylvie (Laboratoire Cerba 201703 CEO) | Chief Executive Officer (CEO) | Cerba (Group) | Île-de-France (region) |
| Cahen, Sophie (Ganymed Robotics 202207 CEO + Co-Founder) | Chief Executive Officer (CEO) | Ganymed Robotics SAS | Île-de-France (region) |
| Cailleteau, Sandrine (Bryan Garnier 202110 Managing Director) | Managing Director | Bryan, Garnier (Group) | Île-de-France (region) |
| Calais, Philippe (Antisense Pharma 201205– Managing Director CEO before Roche + ICI et al) | Managing Director | Isarna Therapeutics GmbH | Bayern (federal state) |
| Calenda, Valérie (Mérieux 201604 Partner at Mérieux Développement) | Partner (venture partner) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Camblong, Jurgi (Sophia Genetics 201407 CEO + Co-Founder) | Chief Executive Officer (CEO) | Sophia Genetics (Group) | Région Lémanique (region) |
| Camboni, Gabriella (Sofinnova Partners 202312 Partner before PinCell + BiovelocITA + EOS SpA + Novupharma) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Cameron, Gordon (Quotient Bioresearch 2007– CFO before Acambis 2004–200706 CEO before CFO before NM Rothschild) | Chief Financial Officer (CFO) | Quotient Bioresearch (Group) | East of England (region) |
| Campbell, Nicholas (Median Technologies 201611–CCO based in the US before Quintiles) | Chief Commercial Officer (CCO) | Median Technologies (Group) | Massachusetts (federal state) |
| Campbell, Timothy (Symyx 200803 President Symyx Software) | n. a. | Dassault Systèmes (3DS) (Group) | California (federal state) |
| Canet, Emmanuel (Servier 200705 VP RnD) | research & development (RnD, research and development) | Servier (Group) | Île-de-France (region) |
| Cantet-Seguin, Sylvie (FIST SA 201211 Life Sciences Dept Transfer + Licensing Manager) | Cluster Manager | CNRS (Centre National de la Recherche Scientifique) (FR) | Île-de-France (region) |
| Cantore, Alessio (San Raffaele Hospital/Telethon) | Professor | San Raffaele of Monte Tabor Foundation | Lombardia (Lombardy) |
| Cappia, Jean-Marc (201006 VP Marketing Fluid Management Technologies at Sartorius Stedim Biotech) | Sales Manager / Marketing Manager | Sartorius (Group) | Provence-Alpes-Côte d’Azur (region) |
| Carella, Thomas J. (Warburg Pincus 202004 Managing Director) | Managing Director | Warburg Pincus (Group) | New York (federal state) |
| Carelli, Claude (Regulaxis 202205 CEO + Founder) | Chief Executive Officer (CEO) | Regulaxis SAS | Île-de-France (region) |
| Carey, Melody (Rx Communications 201602) | Public Relations Manager / Investor Relations Manager | Rx Communications Group LLC (RxIR) | New York (federal state) |
| Carlioz, Sylvain (Stimunity 201604 CEO) | Chief Executive Officer (CEO) | Stimunity SAS | Île-de-France (region) |
| Carlson, Margaret K. (Alira Health 202005 CFO) | Chief Financial Officer (CFO) | Alira Health (CMC Consulting Boston) (Group) | Massachusetts (federal state) |
| Carmagnol, Caroline (Alize RP 201107 CEO + Founder) | Chief Executive Officer (CEO) | Alize RP (Public Relations) | Île-de-France (region) |
| Carnecchia, Max (Accelrys 200907– CEO) | Chief Executive Officer (CEO) | Dassault Systèmes (3DS) (Group) | California (federal state) |
| Carnot, Lionel (EarlyBird 202010 Partner + Bay City Capital 201608 Managing Director) | Managing Director | Bay City Capital LLC | California (federal state) |
| Carouge, Dominique (Sanofi 201802– EVP Head of Business Transformation joined Sanofi 2009 before Ernst & Young) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Carreel, Eric (Indigo) | n. a. | Indigo (holding company of Eric Carreel) | |
| Carrera, Jordi (STAT-Diagnostica 201305 CEO + Co-founder) | Chief Executive Officer (CEO) | Qiagen (Group) | Catalonia |
| Cartier, Nicolas (Mérieux 201305– Corporate VP Industrial Microbiology Unit at bioMérieux before Sanofi France) | President/Director/Head Business Group/Unit/Division | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Cartier-Lacave, Nathalie (INSERM + BrainVectis) | Researcher (university / research institute) | France (govt) | Île-de-France (region) |
| Castagnoli, Paola (A*STAR 201008 Scientific Director SIgN) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Singapore (govt) | Singapore (cl=4) |
| Castaldi, Eric (Argen-X 201406–202106 CFO before NicOx CFO LEFT 7/21) | Chief Financial Officer (CFO) | Argenx (Argen-X) (Group) | North Brabant (province, NL) |
| Catsicas, Stefan (SkyViews Life Science 202012 Managing Partner) | Managing Partner (investment firm) | SkyViews Life Science S.A. | Région Lémanique (region) |
| Caumartin, David (Theraclion 201608 CEO) | Chief Executive Officer (CEO) | Theraclion S.A. | Île-de-France (region) |
| Cautreels, Werner (Selecta Biosciences 2012 CEO before CEO of Solvay Pharmaceuticals before Sanofi + Sterling-Winthrop) | Chief Executive Officer (CEO) | Selecta Biosciences (Group) | Massachusetts (federal state) |
| Cavert, Denis (Vaxxel 202004 President + Co-Founder) | Chief Executive Officer (CEO) | Vaxxel SAS | Auvergne-Rhône-Alpes (region) |
| Cawthorn, Robert (Actelion –201109 existent Chairman of Board Directors TO LEAVE BOARD in 2012) | Board member, non-executive | Johnson & Johnson (JnJ) (Group) | Northwestern Switzerland (region) |
| Cayatte, Grégoire (Techlife Capital 202209 Managing Partner) | Managing Partner | Techlife Capital (Group) | France (region/state unspecified) |
| Cecchini, Cherilyn (LifeSci 202006 at LifeSci Communications) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | New York (federal state) |
| Celanire, Sylvain (Augustine Therapeutics 202103– CEO before consultant + Addex Pharmaceuticals + UCB New Medicines) | Chief Executive Officer (CEO) | Augustine Therapeutics (BE) | Flanders (Flemish region) |
| César, Nathalie (EuroPharma 201705 Founder) | Company Founder | Universal Medica Group (UMG) (Group) | Île-de-France (region) |
| Cescut, Julien (Toulouse White Biotech 201601 Manager of Biotransformation + Culture platform) | n. a. | INRA (Institut National de la Recherche Agronomique) (FR) | Occitanie (Occitania) (region) |
| Chambon, Benjamin (Alira Health 202004 Chief Commercial Officer + Co-Founder) | Chief Commercial Officer (CCO) | Alira Health (CMC Consulting Boston) (Group) | Massachusetts (federal state) |
| Chambon, Philippe (EG 427 202103 CEO + LBO France 201811) | Investment Manager | EG 427 (FR, Pinpoint Gene Therapy) | Île-de-France (region) |
| Chambon, Pierre (Genopole Strasbourg 200609 Director) | n. a. | Genopole (GIP Genopole) | Île-de-France (region) |
| Champagne, Dave (Thermo 200512 Vice President) | n. a. | Thermo Fisher (Group) | Massachusetts (federal state) |
| Chancel, Pierre (sanofi-aventis 2007 Senior VP Global Marketing) | n. a. | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Chang, Byeong (IntegrityBio 200301– Founder) | Company Founder | Dassault Systèmes (3DS) (Group) | California (federal state) |
| Chaoui, Mounia (Turenne Capital 201607 Partner) | Partner (venture partner) | Turenne (Group) | Île-de-France (region) |
| Chapman, Paul (Quanterix 201207– CEO before EMD Millipore + Roche) | Chief Executive Officer (CEO) | Quanterix (Group) | Massachusetts (federal state) |
| Charignon, Sylvain (Andera Partners 202104 Managing Partner) | Managing Partner (investment firm) | Andera Partners (FR) | Île-de-France (region) |
| Charky, Caroline (Stilla Technologies 201905 CP Commercial Operations) | Commercial Manager_o | Stilla Technologies (Group) | Île-de-France (region) |
| Charles, Benjamin (DiogenX 201912– CEO + Co-Founder) | Chief Executive Officer (CEO) | DiogenX SAS | Provence-Alpes-Côte d’Azur (region) |
| Charlès, Bernard (Dassault Systèmes 201401 CEO) | Chief Executive Officer (CEO) | Dassault Systèmes (3DS) (Group) | Île-de-France (region) |
| Charles, Susan (Sue) (Instinctif 201611 Managing Partner Life Sciences before College Group + Northbank + HCC De Facto) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
